Goldman Sachs on Vera Therapeutics (VERA): 'We are encouraged by today's update'

June 2, 2026 11:15 AM

Goldman Sachs analyst Paul Choi reiterated a Buy rating and $90.00 price target on Vera Therapeutics (NASDAQ: VERA).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found